Squamous Cell Carcinoma

---

Overview

Squamous Cell Carcinoma (SCC) is a type of lung cancer that falls under the broader category of Non-Small Cell Lung Cancer (NSCLC). It typically originates in the squamous cells, which are flat cells that line the inside of the airways in the lungs. This type of cancer is often found in the central part of the lungs, near the main airway (bronchus).

Symptoms

The symptoms of Squamous Cell Carcinoma can vary but often include:

• Persistent cough
• Coughing up blood (hemoptysis)
• Chest pain that worsens with deep breathing, coughing, or laughing
• Hoarseness
• Unexplained weight loss
• Loss of appetite
• Fatigue
• Shortness of breath
• Recurring respiratory infections such as bronchitis or pneumonia

Standard Treatments

1. Surgery: If the cancer is detected early and is localized, surgical removal of the tumor can be performed. This can involve a lobectomy (removal of a lobe of the lung), pneumonectomy (removal of the entire lung), or wedge resection (removal of a small section of lung).

2. Radiation Therapy: This involves targeting cancerous cells with high-energy rays to kill or shrink tumors. It's often used in conjunction with surgery or for patients who cannot undergo surgery.

3. Chemotherapy: Utilized to kill cancer cells or stop them from growing. It's often used in combination with surgery and/or radiation therapy.

Targeted Therapy

• EGFR Inhibitors: Drugs like erlotinib and gefitinib target the epidermal growth factor receptor (EGFR) mutations commonly found in NSCLC. These treatments have become more prevalent since the early 2000s.

• PD-1/PD-L1 Inhibitors: Immunotherapy drugs such as pembrolizumab (Keytruda) and nivolumab (Opdivo) have been used since around 2015 to block proteins that prevent the immune system from attacking cancer cells.

Experimental Treatments

• Targeted Gene Therapy: New approaches are being explored to directly modify genes associated with cancer growth. While still under clinical trial phases, these methods show promise in personalizing cancer treatment.

• CAR T-Cell Therapy: Though primarily used for blood cancers, research is ongoing to adapt CAR T-cell therapy for use in solid tumors like lung cancer.

Side Effects of Treatments

• Surgery: Risks include bleeding, infection, and complications from anesthesia. Post-surgical recovery can involve significant pain and reduced lung function.

• Radiation Therapy: Side effects may include fatigue, skin irritation at the treatment site, esophagitis, and lung inflammation.

• Chemotherapy: Common side effects include nausea, vomiting, hair loss, increased risk of infection, fatigue, and anemia.

• Targeted Therapy: Side effects can vary but often include skin rash, diarrhea, and liver function changes.

• Immunotherapy: Side effects might include fatigue, skin reactions, and flu-like symptoms. In rare cases, severe immune-related side effects can occur.

Modern Developments

The landscape of lung cancer treatment has evolved significantly over the past two decades. The introduction of targeted therapies in the early 2000s and the rise of immunotherapy in the 2010s have greatly expanded the options available to patients. These treatments continue to be refined and improved with ongoing research, offering hope for more effective management of Squamous Cell Carcinoma.

It's important to note that while advancements have been made, lung cancer remains a challenging disease, and ongoing research is crucial for the development of more effective and personalized treatment strategies. Always consult healthcare professionals for the most current treatment guidelines and options.